Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Sabouraud

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Fundamental & Clinical Pharmacology|January 1, 1990
Randomized double-blind trial of injectable heptaminol for controlling spontaneous or bromocriptine-induced orthostatic hypotension in parkinsoniansD Milon, H Allain, J M Reymann, et al.
Psychopharmacology|January 1, 1980
The use of bromocriptine for testing central dopaminergic reactivityH Allain, J M Reymann, D Bentue-Ferrer, et al.
Immunogenetics|January 1, 1985
Association of class II HLA-DQ beta chain DNA restriction fragments with multiple sclerosisA Marcadet, C Massart, G Semana, et al.
Revue Neurologique|October 1, 1978
[Progressive myoclonic encephalopathy in dialysis patients. Clinical, electroencephalographic and neuropathological study. Pathogenetic discussion]O Sabouraud, M Chatel, F Menault, et al.
Fundamental & Clinical Pharmacology|January 1, 1988
Randomized, double-blind trial of exifone versus cognitive problems in Parkinson's diseaseH Allain, J Denmat, D Bentue-Ferrer, et al.
Human Immunology|March 1, 1995
TAP2 gene polymorphism contributes to genetic susceptibility to multiple sclerosisH Moins-Teisserenc, G Semana, M Alizadeh, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1997
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteriaG Edan, D Miller, M Clanet, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Fundamental & Clinical Pharmacology|January 1, 1990
Randomized double-blind trial of injectable heptaminol for controlling spontaneous or bromocriptine-induced orthostatic hypotension in parkinsoniansD Milon, H Allain, J M Reymann, et al.
Psychopharmacology|January 1, 1980
The use of bromocriptine for testing central dopaminergic reactivityH Allain, J M Reymann, D Bentue-Ferrer, et al.
Immunogenetics|January 1, 1985
Association of class II HLA-DQ beta chain DNA restriction fragments with multiple sclerosisA Marcadet, C Massart, G Semana, et al.
Revue Neurologique|October 1, 1978
[Progressive myoclonic encephalopathy in dialysis patients. Clinical, electroencephalographic and neuropathological study. Pathogenetic discussion]O Sabouraud, M Chatel, F Menault, et al.
Fundamental & Clinical Pharmacology|January 1, 1988
Randomized, double-blind trial of exifone versus cognitive problems in Parkinson's diseaseH Allain, J Denmat, D Bentue-Ferrer, et al.
Human Immunology|March 1, 1995
TAP2 gene polymorphism contributes to genetic susceptibility to multiple sclerosisH Moins-Teisserenc, G Semana, M Alizadeh, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1997
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteriaG Edan, D Miller, M Clanet, et al.
Pageof 6